HROW - Harrow subsidiary ImprimisRx gets new CEO October, 06 2025 07:44 AM Harrow Health Inc. 2025-10-06 07:44:09 ET More on Harrow Health Harrow, Inc. (HROW) Analyst/Investor Day Transcript Harrow: Buy A Blend Of Value And Growth Harrow: A Classical GARP Stock Harrow to buy Melt Pharmaceuticals Harrow launches $250M debt offering For further details see: Harrow subsidiary ImprimisRx gets new CEO